Arkansas Cardiology Symposium
Registration Form
7:00 a.m. Registration, Continental Breakfast, and Exhibits
7:50 a.m. Welcome and Opening Remarks, Invocation
- Jay Geoghagan, MD, FACC
- David Jones, MD, FACC
- Steve Greer, MD, FACC, FACP
8:00 a.m. Dysautonomia
Steve Greer, MD, FACC
8:30 a.m. Screening Consequences: Coronary and Aortic Calcification
Christen Johnson, MD
9:00 a.m. Interpretation of Non-Invasive Testing
- Kirby Von Edwin, MD, FACC
9:30 a.m. Morning Break and Exhibits
9:45 a.m. Patient Experience: TAVR (Video)
- Evan Watts, MD
10:15 a.m. Coronary Artery Disease
- David Jones, MD, FACC
10:45 a.m. Diabetes Drugs for Non-Diabetics with Cardiac Risk/Disease (SGLT2i/GLP-1)
- Ramey Marshell, MD
11:15 a.m. Peripheral Artery Disease: Basics for the PCP
- Hani Turkmani, MD
11:45 a.m. Lunch and Exhibits
12:45 p.m. EKG Rapid Fire
- Jay Geoghagan, MD, FACC
- David Jones, MD, FACC
1:15 p.m. A Review of the Clinic Management of Acute/Subacute TIA/Stroke
- Joe Hackler, DO, FACC
1:45 p.m. Vitamins and Supplements: What is evidence in Heart Disease
- Tom Conley, MD, FACC, FSCAI
2:15 p.m. Afternoon Break and Exhibits
2:30 p.m. Lipid Management: Statins and Alternatives
- Jay Geoghagan, MD, FACC
3:00 p.m. Left Atrial Appendage Devices
- Blake Norris, MD, FACC
3:30 p.m. Adjourn
Objectives
- Review ACC/AHA guidelines related to the treatment of poorly controlled hypertension.
- Review options for hypertension management.
- Discuss types of Aortopathy.
- Review known causes of Aortopathy.
- Discuss the appropriate duration of dual antiplatelet therapy after coronary stenting.
- Review the data for short- and long-term dual anti-platelet therapy.
- Discuss sports recommendations in post-COVID patients.
- Know the rationale and suggested use of the AHA/ACC Eligibility and Disqualification Recommendations for Competitive Athletes.
- Review the current technological advances in the interventional management ofstructural heart diseases, including minimally invasive heart valve interventionson aortic, mitral and tricuspid disease.
- Discuss improvements to safety, quality and patient satisfaction surroundingnon-surgical structural procedures.
- Discuss risk factors for Women with known coronary artery disease.
- Evaluate treatment options for Women with known coronary artery disease.
- Explain how managing health behaviors and risk factors are an important aspectof lowering the risk of cardiovascular disease.
- Discuss exercise strategies for patients with known cardiac disease.
- Review clinical treatment strategies to address patients with Heart Failure withReduced Ejection Fraction (HFrEF).
- Assess the implications of new treatments for HFrEF.
- Review clinical treatment strategies to address patients with Heart Failure withpreserved Ejection Fraction (HFpEF).
- Assess medications used to treat HFpEF.
- Review normal and abnormal ECG findings.
- Determine appropriate treatment options for specific arrhythmias.
- Review clinical literature relating to novel anticoagulant medications.
- Discuss the complications of atrial fibrillation and the reasoning behind theprescribing of an anticoagulant.
- Review Dietary trends and discuss the role they play in overall CardiovascularHealth.